To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/996) - attachment 1 (PDF)

Found: Report Run Date: 19-Oct-2022, Page 1 Case Series Drug Analysis Print Name: FOI 22/996 Rotavirus Vaccine

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 9 (PDF)

Found: Report Run Date: 14-Oct-2022, Page 1 Case Series Drug Analysis Print Name: Rotavirus Vaccine Analysis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022
Document: Freedom of Information request (FOI 22/1107) - attachment 5 (PDF)

Found: Report Run Date: 23-Nov-2022, Page 1 Case Series Drug Analysis Print Name: MMRvaxPro Vaccine Analysis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 12 (PDF)

Found: Report Run Date: 14-Oct-2022, Page 1 Case Series Drug Analysis Print Name: DTaP/IPV/Hib/HepB Vaccine

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 2 (PDF)

Found: Report Run Date: 14-Oct-2022, Page 1 Case Series Drug Analysis Print Name: Hib/MenC Vaccine Analysis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/996) - attachment 3 (PDF)

Found: Report Run Date: 19-Oct-2022, Page 1 Case Series Drug Analysis Print Name: FOI 22/996 DTaP/IPV/Hib/HepB

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 7 November 2022
Document: Freedom of Information request (FOI 22/1069) - attachment 2 (PDF)

Found: Report Run Date: 19-Oct-2022, Page 1 Case Series Drug Analysis Print Name: FOI 22/996 DTaP/IPV/Hib/HepB

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022
Document: Freedom of Information request (FOI 22/1107) - attachment 3 (PDF)

Found: Report Run Date: 23-Nov-2022, Page 1 Case Series Drug Analysis Print Name: Infanrix Hexa Vaccine Analysis

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 5 December 2022
Document: FOI 22/1102 - attachment 1 (PDF)

Found: Report Run Date: 14-Oct-2022, Page 1 Case Series Drug Analysis Print Name: DTaP/IPV/Hib/HepB Vaccine

Written Question
Revenue and Customs: Consultants
Tuesday 30th April 2024

Asked by: John Hayes (Conservative - South Holland and The Deepings)

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, how much HM Revenue and Customs has spent on external consultancies in the last five years.

Answered by Nigel Huddleston - Financial Secretary (HM Treasury)

HMRC spend on consultancy is reported in HMRC Annual Report and Accounts published on GOV.UK. Consultancy spend for the last 5 five years can be accessed from these links:

HMRC annual report and accounts: 2018 to 2019 - GOV.UK (www.gov.uk) HMRC Annual Report and Accounts 2018 to 2019 (Print). Page 128.

HMRC annual report and accounts: 2019 to 2020 - GOV.UK (www.gov.uk) HMRC Annual Report and Accounts 2019 to 2020 (Print). Page 140.

HMRC annual report and accounts: 2020 to 2021 - GOV.UK (www.gov.uk) HMRC Annual Report and Accounts 2020 to 2021 (Print). Page 171.

HMRC annual report and accounts: 2021 to 2022 - GOV.UK (www.gov.uk) HMRC Annual Report and Accounts 2021 to 2022 (Print). Page 139.

HMRC annual report and accounts: 2022 to 2023 - GOV.UK (www.gov.uk) HMRC Annual Report and Accounts 2018 to 2019 (Print). Page 140.